rheumatologyadvisor12h
Vagus Nerve Stimulation Device Reduces Symptoms of Rheumatoid Arthritis
Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.
rheumatologyadvisor1d
Transitioning to E-Cigarettes Aids Resolution of Respiratory Symptoms
Transitioning from cigarettes to electronic cigarettes (e-cigarettes) is associated with resolution of respiratory symptoms, but the rate of resolution is reduced among those who switch to dual use or ...
rheumatologyadvisor2d
COVID-19 Pandemic-Linked Increase in Alcohol Use Persisting
The prevalence of any alcohol use and heavy alcohol use was higher in 2020 and 2022 compared with 2018. HealthDay News — The prevalence of any alcohol use and heavy alcohol use was higher in 2020 and ...
rheumatologyadvisor2d
Asthma Linked to Memory Difficulties in Children
HealthDay News — Asthma is associated with memory difficulties in children, according to a study published online Nov. 11 in JAMA Network Open.
rheumatologyadvisor3d
Total Hip Replacement Revision Rates Vary With Type of Material Used
For patients undergoing primary total hip replacement (THR), the rate of revision varies by type of material used in the bearing surface. HealthDay News — For patients undergoing primary total hip ...
rheumatologyadvisor9d
Emrosi Approved to Treat Inflammatory Lesions of Rosacea
The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...
rheumatologyadvisor3d
Calcium Levels Decrease Less With Each Subsequent Denosumab Dose in Advanced CKD
Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.
rheumatologyadvisor3d
Health Literacy-Informed Digital Intervention Reduces Obesity at Age 2 Years
A health literacy-informed digital intervention reduces the incidence of obesity at 24 months of age. HealthDay News — A health literacy-informed digital intervention reduces the incidence of obesity ...
rheumatologyadvisor3d
Secukinumab vs Adalimumab More Effective for Skin Symptoms in PsA
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.
rheumatologyadvisor7d
Pain Management Is Holistic Care Beyond ‘Procedures,’ Pain Specialists Contend
Pain medicine should be holistic, with a focus on providing pain relief and an improved quality of life, rather than just about performing procedures.
rheumatologyadvisor3d
COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease
HealthDay News — COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Nov. 6 in JAMA Dermatology.
rheumatologyadvisor4d
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually ...